title: Evolving role of magnetic resonance imaging in renal cancer imaging.
abstract: MRI is an imaging modality that is used in the evaluation and treatment of renal cancer. Although less frequently used than CT, MRI is useful in several aspects of renal cancer evaluation and may have some advantages. MRI has shown promising results for renal cancer staging (especially determination of vascular invasion by tumor), in differentiating malignant from benign complex cystic renal lesions, and in the treatment and follow-up of minimally invasive ablative therapies for renal cancer. In addition, new research shows promise for novel applications of MRI. Herein we review the evolving of MRI in renal cancer imaging.
authors.affiliation: Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. beisner@partners.org
authors.forename: Brian H
authors.initials: BH
authors.lastname: Eisner
authors.forename: Michael P
authors.initials: MP
authors.lastname: Kurtz
authors.forename: Mukesh G
authors.initials: MG
authors.lastname: Harisinghani
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000175:diagnosis* / Q000628:therapy*; D017115:Catheter Ablation; D003452:Cryosurgery; D005682:Gadolinium / Q000009:adverse effects; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D008279:Magnetic Resonance Imaging / Q000639:trends; D009367:Neoplasm Staging; D054989:Nephrogenic Fibrosing Dermopathy / Q000209:etiology; D019275:Radiopharmaceuticals / Q000009:adverse effects
chemical_list: D020533:Angiogenesis Inhibitors; D019275:Radiopharmaceuticals; D005682:Gadolinium